Women with at least one C or G allele, for the ESR1 rs2234693 and rs9340799 respectively, had a significantly decreased risk of dying from all causes with current HT, while those homozygous TT or AA had a significantly increased risk of cancer-related death with HT. Here, ESR1 is linked to hematocrit.